Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 10Genitourinary 6Thoracic 5Gastrointestinal 5Tumor-Agnostic 3Head & Neck 3Breast 3Other hematologic neoplasm 2Lymphoid 2Gynecologic 2CNS 2Sarcoma 1Plasma cell 1Other solid neoplasm 1

Conditions

Lymphoma, Non-Hodgkin 21Leukemia, Lymphocytic, Chronic, B-Cell 14Lymphoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Follicular 9Leukemia, Myeloid, Acute 9Hodgkin Disease 7Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Leukemia 6Myelodysplastic Syndromes 5Multiple Myeloma 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma, B-Cell 5Hematologic Neoplasms 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Burkitt Lymphoma 4Stomach Neoplasms 3Recurrence 3Lymphoma, Large-Cell, Immunoblastic 3Colorectal Neoplasms 3Waldenstrom Macroglobulinemia 2Neoplasms 2Neoplasm Metastasis 2Melanoma 2Leukemia, Myelomonocytic, Juvenile 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Thrombocythemia, Essential 1

Interventions

Cyclophosphamide 35Rituximab 33venetoclax 24ibrutinib 14Vincristine 14Prednisone 14Doxorubicin 14Gemcitabine 13pembrolizumab 12fludarabine 12Bendamustine Hydrochloride 11Etoposide 10obinutuzumab 9Filgrastim 9Dexamethasone 9Bortezomib 9fludarabine phosphate 8Mycophenolic Acid 8Drug Therapy 8ofatumumab 7Whole-Body Irradiation 7Sirolimus 7Peripheral Blood Stem Cell Transplantation 7Methotrexate 7Busulfan 7Therapeutics 6Radiotherapy 6Mesna 6Lenalidomide 6Ipilimumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Interleukin-2 × Lymphoid × Clear all
NCT07410494 2026-02-18

SELECT-CAR-NK

Essen Biotech

Phase 1/2 Recruiting
85 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Liver Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute

NCT00941928 2014-05-22

Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)

M.D. Anderson Cancer Center

Phase 2 Terminated
2 enrolled 3 charts
LymphoidOther hematologic neoplasm

Leukemia, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡